CME Group Inc. $CME Shares Bought by Trifecta Capital Advisors LLC

Trifecta Capital Advisors LLC boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 59.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 113 shares of the financial services provider’s stock after acquiring an additional 42 shares during the quarter. Trifecta Capital Advisors LLC’s holdings in CME Group were worth $31,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in CME. Farther Finance Advisors LLC lifted its position in CME Group by 11.4% in the first quarter. Farther Finance Advisors LLC now owns 5,506 shares of the financial services provider’s stock valued at $1,444,000 after purchasing an additional 563 shares during the period. Wealthcare Advisory Partners LLC lifted its position in CME Group by 3.6% in the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider’s stock valued at $356,000 after purchasing an additional 47 shares during the period. GAMMA Investing LLC lifted its position in CME Group by 24.5% in the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock valued at $1,859,000 after purchasing an additional 1,381 shares during the period. Assenagon Asset Management S.A. lifted its position in CME Group by 649.6% in the first quarter. Assenagon Asset Management S.A. now owns 113,836 shares of the financial services provider’s stock valued at $30,200,000 after purchasing an additional 98,650 shares during the period. Finally, CX Institutional lifted its position in CME Group by 10.1% in the first quarter. CX Institutional now owns 2,876 shares of the financial services provider’s stock valued at $763,000 after purchasing an additional 265 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of a number of recent analyst reports. Morgan Stanley raised their price objective on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research report on Wednesday, October 1st. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research report on Thursday, September 25th. UBS Group reduced their price target on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research report on Monday, September 8th. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research report on Wednesday. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $275.17.

CME Group Trading Up 0.5%

Shares of CME Group stock opened at $264.94 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The company has a market capitalization of $95.48 billion, a P/E ratio of 25.65, a P/E/G ratio of 5.56 and a beta of 0.41. The business has a 50 day moving average price of $269.26 and a 200 day moving average price of $271.06.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $2.56 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. Sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is currently 48.40%.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.